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Abstract
Saturated fatty acids, such as palmitate, are elevated in metabolically dysfunctional condi-
tions like type 2 diabetes mellitus. Palmitate has been shown to impair insulin sensitivity and
suppress protein synthesis while upregulating proteolytic systems in skeletal muscle.
Increased sarco/endoplasmic reticulum (ER) stress and subsequent activation of the
unfolded protein response may contribute to the palmitate-induced impairment of muscle
protein synthesis. In some cell types, ER stress occurs through activation of the Toll-like
receptor 4 (TLR4). Given the link between ER stress and suppression of protein synthesis,
we investigated whether palmitate induces markers of ER stress and protein synthesis by
activating TLR4 in cultured mouse C2C12 myotubes. Myotubes were treated with vehicle, a
TLR4-specific ligand (lipopolysaccharides), palmitate, or a combination of palmitate plus a
TLR4-specific inhibitor (TAK-242). Inflammatory indicators of TLR4 activation (IL-6 and
TNFα) and markers of ER stress were measured, and protein synthesis was assessed
using puromycin incorporation. Palmitate substantially increased the levels of IL-6, TNF-α,
CHOP, XBP1s, and ATF 4 mRNAs and augmented the levels of CHOP, XBP1s, phospho-
PERK and phospho-eIF2α proteins. The TLR4 antagonist attenuated both acute palmitate
and LPS-induced increases in IL-6 and TNFα, but did not reduce ER stress signaling with
either 6 h or 24 h palmitate treatment. Similarly, treating myotubes with palmitate for 6 h
caused a 43% decline in protein synthesis consistent with an increase in phospho-eIF2α,
and the TLR4 antagonist did not alter these responses. These results suggest that palmitate
does not induce ER stress through TLR4 in muscle, and that palmitate impairs protein syn-
thesis in skeletal muscle in part by induction of ER stress.
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Introduction
Skeletal muscle atrophy reduces muscle function, quality of life, functional independence, and
is a consequence in many diseases and conditions including cancer, heart failure, sepsis,
chronic kidney disease and type 2 diabetes mellitus (T2DM) [1, 2]. In T2DM, skeletal muscle
becomes metabolically dysregulated through a combination of insulin resistance, inflamma-
tion and lipotoxicity, all of which may contribute to the development of muscle atrophy
through a combination of impaired protein synthesis and accelerated proteolysis via autop-
hagy, the caspases, and the ubiquitin proteasome pathway [3]. Patients with T2DM also have
dyslipidemia and increased lipid accumulation in skeletal muscle which may contribute to
insulin resistance, a condition linked to muscle wasting [4–7]. In cultured myotubes, exoge-
nous saturated fatty acids such as palmitate (PA) upregulate pro-inflammatory signaling,
impair insulin signaling, reduce myotube size and increase protein degradation, indicating the
saturated fatty acids directly affect muscle fiber metabolism [8–11].
The status of the endoplasmic reticulum (sarcoplasmic reticulum in muscle) is a significant
determinant of protein homeostasis in muscle cells. Accumulation of unfolded proteins and
other physiological stresses produce ER stress which initiates the unfolded protein response
(UPR). The UPR is a vital cell survival signaling pathway that acts to both decrease overall pro-
tein synthesis and increase the activities of several proteolytic systems [12, 13]. The UPR con-
sists of three signaling branches which are initiated by signals such as the dissociation of BiP
(GRP78) from the intracellular receptor domains of the ER. These signals activate combina-
tions of the three stress sensors, protein kinase RNA-like endoplasmic reticulum kinase
(PERK), activation transcription factor 6 (ATF6) and inositol-requiring enzyme 1 α (IRE 1α).
PERK-initiated signaling is particularly relevant to protein homeostasis due to the consider-
able range of UPR-related genes it targets [14] and its ability to modulate several aspects of
protein metabolism [15, 16]. Activation of PERK directly impacts protein synthesis via phos-
phorylation of eukaryotic inducible factor 2 α (eIF2α), which inhibits the eIF2•GTP•Met-
tRNAi protein translation complex. Downstream of PERK and eIF2α, activation transcription
factor 4 (ATF4) and transcription factor C/EBP homologous protein (CHOP) activate autop-
hagy signaling and induce caspase 3, likely via caspase-12 [17]. Indeed, activation of ATF4
induces muscle atrophy in mice and decreases protein synthesis [18, 19], while activation of
caspase-3 via CHOP and other sources contributes to the accelerated rate of proteolysis
through cleavage of actin and other cellular proteins as well as activation of some subunits of
the proteasome in skeletal muscle, but does necessarily induce cell death [20, 21]. The IRE1α-
and ATF6-initiated branches of the UPR converge to increase transcription of the spliced vari-
ant of X-box binding protein 1 (XBP1s), which is a transcription factor that induces BiP
expression, particularly when combined with ATF6 [22–24]. XBP1s also works in conjunction
with ATF6 and ATF4 to maximally induce transcription of CHOP [25, 26].
Our lab has previously reported that PA acts directly on C2C12 myotubes to increase the
rate of protein degradation and induce caspase-3 [8, 13]. Concomitant with this response,
nuclear translocation of the atrophy-related transcription factor, forkhead box O 3a (FoxO3a),
was increased as was expression of the atrophy-inducing E3 ubiquitin ligase, atrogin-1 (also
known as MAFbx) [8]. In addition, PA increased phosphorylation of eIF2α and reduced pro-
tein synthesis in C2C12 myotubes, and a high fat diet induced similar responses in muscle of
aged mice [13, 15]. These findings suggest that saturated fats and obesity may act directly on
muscle fibers to decrease protein synthesis by inducing the PERK-initiated branch of the UPR.
The mechanisms by which PA induces ER stress in tissues remains elusive. Inflammation
and ER stress are intrinsically linked, with ER stress activating pro-inflammatory signaling
such as c-Jun N-terminal kinases (JNK) and nuclear factor κ-B (NF-κB) through multiple
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UPR branches [16, 27]. Furthermore, inflammatory pathways may also induce ER stress. In
lung, immune, and liver cells, lipopolysaccharide (LPS) induces ER stress and inflammatory
cytokine production [28–30]. These responses to LPS are primarily mediated by activation of
toll-like receptor 4 (TLR4) which induces a variety of pro-inflammatory proteins including
NF-κB and AP-1 [31]. Although it remains unclear if TLR4 induces ER stress in skeletal mus-
cle, there is evidence suggesting that activation of TLR4 by LPS is affiliated with muscle atro-
phy. C2C12 myotubes treated with LPS had reduced myotube diameter and increased
activation of the ubiquitin proteasome and autophagy [32]. ER stress is linked to ubiquitin
proteasome and autophagy signaling, and can reduce protein synthesis [12]. In addition to
LPS, saturated fatty acids may also activate TLR4 in muscle [33, 34], suggesting that PA-
induced atrophy may be in part due to activation of this receptor and the resulting ER stress.
TLR4 is inhibited by TAK-242, a highly specific pharmaceutical inhibitor of TLR4 intracellular
signaling, with no inhibitory effects on other TLRs [35, 36]. In myotubes, TAK-242 blocks
LPS-induced inflammatory responses [37]. Pierre et al., [38] also demonstrated that global
knockout of TLR4 in mice attenuated a high fat diet-induced increase in BiP, XBP1 s and
CHOP in skeletal muscle, liver and adipose tissue. However, given that TLR4 expression was
ablated in all tissues in that study [38], it is difficult to definitively conclude whether the reduc-
tion in muscle ER stress was due to the direct effect of TLR4 knockout in muscle or to the indi-
rect effects of ablating TLR4 in other tissues (e.g., reduced circulating inflammatory signals).
Given the potential overlap between TLR4, ER stress, and protein turnover, we investigated
the role of TLR4 on ER stress signaling and protein synthesis in PA-treated C2C12 myotubes.
This model eliminates the confounding and indirect effects of PA on other cell types and
allows a more direct interrogation of the interaction between TLR4, ER stress, and protein syn-
thesis in muscle cells.
Methods
Cell culture
C2C12 myoblasts, derived from mice and obtained from American Type Culture Collection
(Manassas, VA, USA) were grown in Dulbecco’s Modified Eagle Medium (DMEM) containing
4.5 g/L glucose and supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Law-
renceville, GA, USA) and antibiotics (1% of final media volume consisting of 100 U/mL peni-
cillin and 100 μg/mL streptomycin; Invitrogen, Carlsbad, CA, USA). At 90–95% confluence,
cells were induced to differentiate into myotubes by replacing the growth media with DMEM
containing 4.5 g/L glucose plus 2% horse serum (Invitrogen) and antibiotics for 4 days before
initiating experimental treatments.
Experimental treatments
Lipopolysaccharides (LPS; E.Coli 0128:B12, Sigma Aldrich, St. Louis, MO, USA) were diluted
in DMEM before being added to the treatment media, which consisted of DMEM plus 2%
bovine serum albumin (BSA; Fraction V BSA; Roche, Indianapolis, IN, USA), 2% FBS, and 1%
antibiotics at a final concentration of 100 ng/mL. Palmitate (PA) (Sigma Aldrich) was dis-
solved in ethanol and added to the treatment media at a final concentration of 500 μM. These
concentrations of PA and BSA were chosen as 2% BSA and 500 μmol/L free fatty acids are sim-
ilar to the final molar ratio of human plasma [39], and fasting plasma nonesterified fatty acids
are around 600 μmol/L in obese adults with impaired glucose tolerance or diabetes [40]. The
TLR4-specific inhibitor TAK-242 (CLI-095, InvivoGen, San Diego, CA, USA) was diluted in
DMSO and added to the treatment media at a final concentration of 1 μM [35]. This concen-
tration (1 μM) of TAK-242 specifically inhibits only intracellular TLR4 signaling, and does not
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affect signaling from other TLRs [35, 36]. Furthermore, 1μM TAK-242 has been previously
shown to inhibit LPS induced pro-inflammatory signaling in cultured myotubes [37]. Before
the LPS or PA co-treatment with TAK-242, myotubes underwent a 30 minute pre-treatment
with TAK-242. Control cells included the vehicle (ethanol and DMSO), and all treatments
contained the same final percentage of BSA (2%), ethanol (0.5%) and DMSO (0.1%).
RNA isolation and qRT-PCR analysis
Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA, USA) and reverse tran-
scribed using the Superscript III First-Strand Synthesis kit (Invitrogen) according to the
manufacturers’ instructions. Specific mRNAs were measured by quantitative real time PCR
in a BioRad iCycler with iQ SYBR Green reagent (BioRad Laboratories, Hercules, CA, USA)
and previously published primer sets for ATF4 [41], CHOP, XBP1s [42], MCP-1, TNF-α
[43] and IL-6 [44]. 18S rRNA was used as the normalization control. The data were analyzed
for fold change (ΔΔCt) using the iCycler software as described previously [45]; treatment
values are expressed relative to control. Melt curve analyses were performed to verify the
specificity of the reaction.
Western blot analysis
Whole cell lysates were prepared using buffers specified by the antibody vendors and cleared
of cellular debris by centrifugation at 14,000g for 15 min. The concentrations of protein in the
lysates were measured using a BioRad DC Protein Assay (BioRad Laboratories, Hercules, CA).
Western blot analyses were performed as described previously [46] using nitrocellulose mem-
branes and commercial antibodies to phospho-PERK (T980), PERK, phospho-eIF2α (S51),
eIF2α, CHOP, (Cell Signaling Technology, Beverly, MA, USA), spliced XBP1 (clone 9D11A43,
Biolegends, San Diego, CA, USA), phospho-p70S6K (Sigma) and p70S6K (Thermo Fisher, Wal-
tham, MA, USA). Equal protein loading and electroblot transfer were verified by staining the
membrane post transfer with Ponceau S Red. This method has been routinely used by our lab
[45] and has been validated as a reliable measure of protein loading with immunoblotting [47].
It also alleviates the need to validate a control protein each time a treatment or culture condi-
tion is modified. Following the chemiluminescence step, densities of detected protein bands
were determined using Image J (NIH, Bethesda, MD, USA).
Protein synthesis assay (SUnSET)
Protein synthesis was measured as previously described using the SUrface SEnsing of Transla-
tion (SUnSET) method which measures the incorporation of puromycin into nascent peptide
chains [48, 49]. In brief, puromycin dihydrochloride (EMD Millipore, Temecula, CA, USA)
was added to the cell treatment media (1 μM final concentration) for 30 min prior to cell lysis
with a standard RIPA buffer [45]. Twenty micrograms of protein were separated in a 10%
polyacylamide gel under denaturing conditions until the dye-front was ~1.5 cm from the bot-
tom of the gel. Proteins were transferred to nitrocellulose membranes (BioRad) that were sub-
sequently incubated in TBST buffer containing 5% skim milk powder and incubated overnight
with a monoclonal antibody to puromycin (clone 12D10, Millipore EMD, diluted 1:5,000)
diluted in TBST containing 1% BSA. Membranes were then incubated for 1 h in TBST con-
taining 5% skim milk plus a secondary IgG2a antibody (Jackson ImmunoResearch, West
Grove, PA, USA, diluted 1:45,000). The total lane density was analyzed using Image J (NIH).
TLR4 and palmitate-induced ER stress in skeletal muscle
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Statistical analyses
Data are presented as mean percentage of control ± SD. Differences between treatments are
compared by one-way ANOVA with post-hoc analysis using a Fisher’s least significant differ-
ence test, except when testing for differences in XBP1s mRNA. In this case, the response to
treatment was analyzed using the non-parametric Kruskal-Wallis test. For most experiments,
data was calculated as the mean of 3–6 independent experiments, with 2–3 replicates per
experiment. The one exception was the experiment which tested the efficacy of TAK-242 in
LPS-treated cells (Fig 1A and 1B); in this case; two separate experiments with three replicates
per experiment were performed. The statistical sample size is listed in each figure legend.
Results are considered statistically significant at p< 0.05. Statistical analyses and figures were
generated using Graphpad Prism (GraphPad Software, Inc, La Jolla, CA, USA).
Results
TLR4 inhibition attenuates acute LPS-induced mRNA markers of
inflammation, but not palmitate-induced inflammation
Both TNFα and IL-6 signaling are commonly reported, reliable indicators of TLR4 activation
in the presence of TLR ligands such as LPS [35, 36]. Hence, to demonstrate the efficacy of the
TLR4 inhibitor (TAK-242) in our experimental model, we evaluated the effects of LPS and
TAK-242 on IL-6 and TNFα mRNA levels in C2C12 myotubes. Consistent with previous stud-
ies [37], acute LPS treatment (3 h) caused a 4.3-fold increase in IL-6 and a 4.8-fold increase in
TNFα mRNA levels, compared to controls (Fig 1, p<0.05). Both responses were ablated by
addition of the TLR4 inhibitor (p<0.05, LPS + TAK242 vs LPS, Fig 1). In addition, IL-6 and
TNFα mRNA levels were increased in response to both 6 h (p<0.05, IL-6 mRNA: 1.6-fold
increase; TNFα:4.4-fold increase) and 24 h (p<0.05, IL-6 mRNA: 14.8-fold increase;
TNFα:15.1-fold increase) PA treatment (500 μM; Fig 1C–1F). TAK-242 inhibited the PA
induced increase in IL-6 and TNFα mRNA at the 6 h timepoint (p<0.05), but not 24 h treat-
ment (Fig 1C–1F).
Palmitate induced ER stress is not prevented by TLR4 inhibition
Previous work has indicated that PA accelerates proteolysis, and induces both atrophy and ER
stress in C2C12 myotubes [8, 9, 15, 50]. The latter finding led us to investigate whether modu-
lation of TLR4 might impact the induction of ER stress and suppression of protein synthesis.
In myotubes treated with vehicle alone or LPS to activate TLR4, phosphorylated PERK (p-
PERK) was undetectable. In contrast, incubation with PA for 24 h significantly increased the
ratio of p-PERK:PERK and co-incubation of PA and TAK242 did not alter the response. (Fig
2A–2D). Consistent with the activation of PERK, PA also increased the ratio of phosphorylated
eIF2α (p-eIF2α:eIF2α) (Fig 2E–2H). In this case, the effect of PA was primarily due a reduction
in total eIF2α protein. Neither LPS nor TAK-242 affected the PA-induced phosphorylation of
eIF2α.
We also evaluated XBP1s which serves as a marker of the integrated input of ATF6 and
IRE1α. XBP1s mRNA and protein were increased by PA (p<0.05, Fig 3A and 3C), but unaf-
fected by co-treatment with TAK-242. Since PERK-eIF2α and XBP1s signaling was activated,
we next evaluated the levels of their common downstream effector, CHOP. CHOP protein was
induced by PA, but unaffected with the addition of TAK-242 (Fig 3B). Similarly, CHOP
mRNA was increased with PA compared to controls (p<0.05). Curiously, the combination of
PA plus TAK-242 increased CHOP mRNA more than PA alone (p<0.05, Fig 3D). Consistent
with the upstream eIF2α phosphorylation, ATF4 mRNA was increased with PA compared to
TLR4 and palmitate-induced ER stress in skeletal muscle
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Fig 1. Pharmacological TLR4 inhibition using TAK-242 reversed acute LPS (3 h) and PA (6 h) induced pro-inflammatory mRNA markers IL-6 and TNFα
(A-D), but did not affect palmitate-induced inflammation in C2C12 myotubes at 24 h (E-F). A-B: 3 h of LPS treatment (100 ng/mL) increased IL-6 and TNF-α
mRNA which was reversed by TLR4 inhibitor, TAK-242 (1 μM, n = 6). C-D: 6 h of palmitate (500 μM) increased both IL-6 and TNFα mRNA expression
compared to controls, and was reversed by treatment with TAK-242 (1 μM, n = 3). E-F: 24 h of palmitate (500 μM) or palmitate with TAK-242 (1 μM) treatments
increased IL-6 and TNF-α mRNA expression relative to controls (n = 4). Values shown are Mean ± SD.  Higher than control (p<0.05), # Lower than LPS
treatment (p<0.05).
https://doi.org/10.1371/journal.pone.0191313.g001
TLR4 and palmitate-induced ER stress in skeletal muscle
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Fig 2. 24 h of palmitate treatment increased p-PERK/PERK and p-eIF2α/eIF2α which were not attenuated by TLR4 inhibition in C2C12
myotubes. A-D: 24 h of palmitate (500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM) induced p-PERK (C), which was not
TLR4 and palmitate-induced ER stress in skeletal muscle
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control (p<0.05, Fig 3E), but not altered with the co-treatment of PA and TAK-242. LPS did
not impact ATF4, XBP1s or CHOP mRNA or protein levels, and inhibition of the TLR4 with
PA did not affect protein levels of CHOP or XBP1s (Fig 3A–3E). Finally, we confirmed that
TAK-242 alone did not alter the basal expression of CHOP, ATF4 or XBP1s mRNAs (Fig 3F).
Protein synthesis is reduced by palmitate concomitant with increased
phosphorylation of eIF2α, and is unaffected by TLR4 inhibition
Next we tested whether protein synthesis was suppressed concurrently with activation of ER
stress. Protein synthesis was measured using the SUnSET method (46) after cell treatments for
6 h because in earlier studies and pilot data, we found that many of the atrophic responses to
PA, such as reduced p-Akt and activation of the ubiquitin proteasome, were most prominent
with 4–6 h after PA treatment [8]. Addition of PA to myotubes for 6 hours led to a 43%
decrease in protein synthesis which was not changed by the addition of TAK-242 (Fig 4A and
4B). Concomitant with the response to PA, the phosphorylation of eIF2α was increased 3.8
fold. Inhibition of TLR4 did not affect the PA-induced changes in protein synthesis or eIF2α
phosphorylation (p<0.05, Fig 4A–4C). We also evaluated the impact of PA on the phosphory-
lation of the ribosomal protein p70S6K, an indicator of mTOR activity. No differences were in
the ratio of p-p70S6K/p70S6K were found between any of the treatment groups (Fig 4D). Finally,
consistent with the findings of eIF2α phosphorylation, TAK-242 did not cause any decrease in
ATF4, XBP1 s or CHOP mRNA levels in response to 6 h PA treatment (Fig 4F–4H).
Discussion
In this study, we investigated the role of TLR4 in PA-induced changes in ER stress and protein
synthesis in cultured C2C12 myotubes. Based on current literature, we hypothesized that PA
activates TLR4, and that inhibition of TLR4 with TAK-242 in myotubes would attenuate ER
stress and the PA-induced suppression of protein synthesis. Our findings confirmed a report
by Hussey et al., [37] that TAK-242, a highly-specific TLR4 inhibitor, blocks the acute induc-
tion of inflammatory cytokine mRNA transcription by both LPS and saturated fatty acids;
however, it did not change the induction of ER stress or the suppression of protein synthesis
by PA. Thus, PA-induced ER stress and declines in protein synthesis in skeletal muscle appear
to be independent of TLR4 activation in vitro.
There are several reports that link TLR4 and ER stress. LPS, a TLR4 ligand, induces expres-
sion of inflammatory cytokines as well as ER stress in lung, intestinal, hepatic and immune tis-
sue/cells [28–30, 51]. In contrast, inhibiting TLR4 in our model inhibited initial PA-induced
cytokine production, but did not prevent the induction of ER stress. One speculative explana-
tion for this difference is that LPS concentrations such as those used in other studies (e.g.,
5–10 mg/kg in mice, 50 ug/mL-10 mg/mL in vitro) [28–30, 51] may achieve a higher level of
TLR4 activation than possible with the concentrations of PA (300–500 μM) typically used with
cultured myotubes [8, 52]. While acute treatment with higher concentrations of PA could
potentially be used to test this theory, concentrations of PA higher than ~500 μM for a sub-
stantial time period would surpass the total concentrations of nonesterified fatty acids seen in
obese and insulin resistant individuals [40]. Considering that PA constitutes only a portion of
detectable with control or LPS treatments (n = 4). E-H: 24 h of palmitate (500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM)
increased the ratio of p-eIF2α/total eIF2α protein (E), and decreased total eIF2α protein (H; n = 6). Representative blots for p-PERK/PERK (B)
and p-eIF2α/eIF2α (F) protein; C = control, L = LPS (100 ng/ml), P = palmitate (500 μM), PT = Palmitate (500 μM) and TAK-242 (1 μM).
Values shown are Mean ± SD.  Different to control (p<0.05).
https://doi.org/10.1371/journal.pone.0191313.g002
TLR4 and palmitate-induced ER stress in skeletal muscle
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Fig 3. 24 h of palmitate treatment increased XBP1 s and CHOP protein expression and were not attenuated by inhibition of TLR4 signaling in
C2C12 myotubes. (A) 24 h of palmitate (500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM) increased XBP1 s protein (n = 4) with
TLR4 and palmitate-induced ER stress in skeletal muscle
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thapsigargin (Tg) used as a positive control. The fainter, lower band in the representative blot was confirmed as non-specific binding by the
manufacturer. (B) 24 h of palmitate (500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM) induced CHOP protein expression (n = 4) with
thapsigargin (Tg) used as a positive control. CHOP was not quantifiable in the control or LPS treated samples. (C) 24 h of palmitate (500 μM) or
palmitate with the TLR inhibitor TAK-242 (1 μM) increased XBP1 s mRNA expression similarly compared to controls (n = 4). (D) 24 h of palmitate
(500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM) increased CHOP mRNA expression compared to controls, while combined palmitate
and TAK-242 treatment elevated CHOP mRNA to levels higher than palmitate (n = 4). (E) 24 h of palmitate (500 μM) or palmitate with TAK-242
(1 μM) increased ATF mRNA expression similarly compared to controls (n = 4). (F-H) TAK-242 alone does not independently change XBP1 s,
ATF4 or CHOP mRNA levels compared to control (n = 3). Values shown are Mean ± SD. C = control, L = LPS (100 ng/ml), P = palmitate (500 μM),
PT = Palmitate (500 μM) and TAK-242 (1 μM). Values shown are mean ± SD.  Higher than control (p<0.05), # Higher than PA (p<0.05).
https://doi.org/10.1371/journal.pone.0191313.g003
Fig 4. 6 h palmitate treatment reduces protein synthesis independent of TLR4 inhibition and concomitant with increased p-eIF2α in C2C12 myotubes. A: Protein
synthesis, measured using puromycin incorporation, was reduced by both 6 h palmitate treatment (500 μM) and palmitate with TLR inhibitor (TAK-242, 1 μM) co-
treatment (n = 3). B: Representative puromycin western blot form a single experiment (C = control, L = LPS (100 ng/ml), P = palmitate (500 μM), PT = Palmitate
(500 μM) and TAK-242 (1 μM). C: 6 h of palmitate (500 μM) or palmitate with the TLR inhibitor TAK-242 (1 μM) increased the ratio of p-eIF2α/total eIF2α protein
(n = 3). D: No differences were found in p-P70S6K/P70S6K following 6 h treatments with LPS, palmitate, or palmitate with TAK-242 co-treatment compared to control
(n = 3). E: Representative blots for p-eIF2α, eIF2α, p-P70S6K and P70S6K from a single experiment. F-H: 6 h palmitate (500μM) increased ATF 4, CHOP and XBP1 s
mRNA expression compared to controls, and were not altered with the addition of the TLR4 inhibitor, TAK-242 (1 μM). Dashed line represents control levels (n = 3).
Values shown are mean ± SD.  Different to control (p<0.05).
https://doi.org/10.1371/journal.pone.0191313.g004
TLR4 and palmitate-induced ER stress in skeletal muscle
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the total pool of nonesterified fatty acids, it would have been difficult to make any physiologi-
cally relevant conclusions in our study if we treated with higher PA concentrations.
Our findings are also in contrast to in vivo findings in mice with a global knockout of TLR4
[38]. In that study, a high-fat diet induced ER stress in the muscles of wild-type mice but not
in TLR4-deficient mice. The authors concluded that TLR4 was linked to ER stress in muscle
[38]. While this conclusion may be true, the global knockout of TLR4 likely caused other adap-
tations independent of skeletal muscle, such as adaptations in other organs or tissues like
inflammatory cells. Furthermore, unlike control animals, the TLR4 knockout mice did not
exhibit any increase in visceral adipose tissue in response to the high-fat diet. The efficacy of
TAK-242 in the inhibition of TLR4 is evident in our study. Previous reports have indicated
that inhibition of TLR4 with TAK-242 (1μM) consistently inhibits increases in IL-6 and TNFα
mRNA levels in multiple cell types [35, 36]. In our study, TAK-242 inhibited acute LPS and
PA-induced IL-6 and TNFα mRNA levels, similar to previously reported findings with L6
myotubes [37]. This indicates that TLR4 participates in the initial PA-induced inflammatory
cytokine responses in muscle. Importantly, TAK-242 has been demonstrated to have minimal
effect on the signaling in other TLRs [35]. Hence, it is highly unlikely that the findings with
TAK-242 in our study were due to non-specific signaling in other TLRs, or failure to ade-
quately inhibit TLR4. Unlike with 6 h treatment, TAK-242 did not prevent the induction of
IL-6 and TNFα mRNA with 24 h PA treatment. This suggests that while TLR4 is involved in
some of the initial induction of pro-inflammatory mRNA expression, longer term expression
of IL-6 and TNFα is mediated by TLR4-independent factors. We can only speculate on the
mechanisms of this response; one potential explanation for the longer-term induction of IL-6
and TNFα with PA is the increase in mitochondrial damage and oxidative stress [39, 53]. In
C2C12 myotubes, PA induced inflammation and ROS production, both of which were both
reduced by resveratrol through a SIRT-1 dependent pathway. Furthermore, the induction of
prolonged ER stress by PA is also likely to directly contribute to inflammation via TLR4-inde-
pendent activation of NF-κB [16]; indeed the increase in ATF4, XBP1 s and CHOP mRNA
expression were far more substantial with the 24 h PA treatments compared to the acute treat-
ment. Hence, the discovery of TLR4-independent instigators of PA-induced inflammation is
an exciting potential area of future research in skeletal muscle.
It is interesting that while the PA-induced upregulation of the UPR was largely unaffected
by TLR4 inhibition, there was one notable exception in the increased expression of CHOP
mRNA with PA+TAK-242. This effect was not consistent with UPR signaling upstream of
CHOP, and perhaps suggests some direct signaling between TLR4 and CHOP exists in muscle.
Indeed, macrophages treated with low-dose LPS (1 ng/mL) to induce TLR4 activation had
reduced protein expression of p-eIF2α and CHOP in response to PA [54], although what rele-
vance this TLR4 activation has on PA-induced upregulation of the UPR in muscle, and
whether this mechanism was involved in our study remains purely speculative. It is notewor-
thy that despite the increase in CHOP mRNA expression with PA+TAK-242, there was no dif-
ference in CHOP protein, suggesting the increased amount of CHOP mRNA expression has
little physiological consequence.
Our results indicate that the induction of ER stress, and the resulting activation of the UPR,
is likely an important aspect of the cellular response to PA that reduces protein synthesis. In
C2C12 myotubes, the reduction in protein synthesis 6 h after PA treatment coincided with
increased PERK-eIF2α signaling but no change in p70S6K phosphorylation. Others have
reported inconsistent effects of PA on p70S6K phosphorylation in skeletal muscle [52, 55], sug-
gesting that the PA-induced decrease in protein synthesis is more likely the result of increased
phosphorylation of eIF2α rather than suppression of mTOR-p70S6K signaling. A report by Tar-
dif et al., [15] found a similar relationship between protein synthesis and the phosphorylation
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of eIF2α in both older rats fed a high-fat diet for 10 weeks and palmitate-treated myotubes.
Hence, ER stress is emerging as an important contributor to the attenuation of protein synthe-
sis in obesity and dyslipidemia. When considering other data indicating that PA upregulates
several proteolytic systems in muscle cells, it becomes apparent that PA is a potent regulator of
multiple aspects of protein turnover in muscle [8, 15].
There are limitations which should be considered when interpreting our research. Per-
haps the most prominent of these limitations is to note that our study was not designed to,
and cannot make inferences about the general effect of inflammation or non-TLR4 pro-
inflammatory pathways on ER stress and the UPR. The scope of our research was limited to
investigating whether TLR4 activation contributed to PA-induced ER stress in skeletal
muscle, to which we found that PA-induced ER stress is independent of TLR4 activation.
We did not investigate pro-inflammatory pathways in depth, such as NF-κB, and only
investigated IL-6 and TNFα as a proxy to assess the effectiveness of TAK-242, and to briefly
assess to what extent the IL-6 and TNFα pathways were mediated by TLR4 in response to
PA. Our results do not provide any evidence regarding whether TNFα, IL-6, NF-κB or any
other important pro-inflammatory signaling axes directly contribute to ER stress, rather
we conclude that PA does not induce ER stress in skeletal muscle via activation of TLR4.
The contributions of inflammation to the ER stress process, either directly or indirectly,
are interesting questions for future research.
In conclusion, our data indicate that TLR4 and its downstream signals are not substantial
mediators of PA-induced ER stress in cultured myotubes. The mechanism of ER stress induc-
tion by PA can only be speculated from our data, but may be related to an increase in cer-
amides and other inflammation-linked molecules like ROS that are regulated by NF-κB and
JNK [55–58]. It is also possible that PA treatment may produce changes in the membrane
phospholipid content of the sarcoplasmic reticulum or mitochondria that are relayed to the
ER stress machinery [59]. Further investigations are needed to explore how saturated fatty
acids induce ER stress in skeletal muscle, but the findings of our research strongly suggest
these factors are independent of TLR4 activation.
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